1) Bartynski WS:Posterior reversible encephalopathy syndrome, part 1:fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036-1042, 2008
2) Beitzke M, Enzinger C, Wünsch G, Asslaber M, Gattringer T, Fazekas F:Contribution of convexal subarachnoid hemorrhage to disease progression in cerebral amyloid angiopathy. Stroke 46:1533-1540, 2015
3) Calabrese LH, Mallek JA:Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine(Baltimore)67:20-39, 1988
4) Jellinger KA, Attems J:Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm(Vienna)115:473-482, 2008
5) 小阪憲司,松下正明,小柳新策,Mehraein P:Lewy小体病の臨床病理学的研究.精神経誌82:292-311, 1980
6) 厚生労働科学研究費補助金 認知症対策総合研究事業:都市部における認知症有病率と認知症の生活機能障害への対応(2011-2012年度総合研究報告書).2013
7) Kumar S, Goddeau RP Jr, Selim MH, Thomas A, Schlaug G, Alhazzani A, Searls DE, Caplan LR:Atraumatic convexal subarachnoid hemorrhage:clinical presentation, imaging patterns, and etiologies. Neurology 74:893-899, 2010
8) Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK;DLB/PDD Working Group:DLB and PDD boundary issues:diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812-819, 2007
9) McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O' Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K:Diagnosis and management of dementia with Lewy bodies;Fourth consensus report of the DLB Consortium. Neurology 89:88-100, 2017
10) Mendel T, Bertrand E, Szpak GM, Stępień T, Wierzba-Bobrowicz T:Complications of severe cerebral amyloid angiopathy in the course of dementia with Lewy bodies. A case report. Folia Neuropathol 48:293-299, 2010
11) 野中俊宏,藥師寺祐介,井手俊宏,伊藤 寛,河本和裕,原 英夫:発症前に多彩な脳アミロイドアンギオパチー関連MRI所見が描出されていたアルツハイマー病合併脳葉型出血の1例.臨床神経56:338-343, 2016
12) Sarti C, Tuomilehto J, Salomaa V, Sivenius J, Kaarsalo E, Narva EV, Salmi K, Torppa J:Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 22:848-853, 1991
13) Shimada H, Shinotoh H, Hirano S, Miyoshi M, Sato K, Tanaka N, Ota T, Fukushi K, Irie T, Ito H, Higuchi M, Kuwabara S, Suhara T:β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy. Mov Disord 28:169-175, 2013
14) 冨本秀和:脳微小血管障害による認知症発症への関与;病因論的考察.神経治療33:194-198, 2016
ε4 Increases Risk for Dementia in Pure Synucleinopathies. JAMA Neurol 70:223-228, 2013
16) Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T:Age-associated prevalence and risk factors of Lewy body pathology in a general population:the Hisayama study. Acta Neuropathol 106:374-382, 2003